MGIA
VBIV

Moneta Group Investment Advisors’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Moneta Group Investment Advisors’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-338
Closed -$34K – 478
2021
Q2 		$34K Buy
+338
New +$32.9K ﹤0.01% 445

Other funds holding VBIV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Moneta Group Investment Advisors's VBIV Position: Q3 2021 in Review

Moneta Group Investment Advisors sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2021, closing a stake of 338 shares — an estimated $34K sold.

Moneta Group Investment Advisors first reported a position in VBIV in Q2 2021 and held it in 1 quarter. The position peaked at $34K in Q2 2021. 126 funds tracked by Wall St. Rank hold VBIV as of Q3 2021.

  • Moneta Group Investment Advisors reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2021 after selling out during the quarter.
  • Moneta Group Investment Advisors sold 338 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2021, an estimated $34K.
  • Moneta Group Investment Advisors first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2021 and held it in 1 quarter.
  • Moneta Group Investment Advisors's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $34K in Q2 2021.
  • 126 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2021.

Based on Moneta Group Investment Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.